QINLOCK (ripretinib) for the Treatment of Gastrointestinal Stromal Tumour
Ripretinib is an inhibitor of tyrosine kinase. Credit: Deciphera Pharmaceuticals, Inc.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more